Johnson Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 55.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 55.00 Cr
as on 26-06-2024
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Johnson Pharmacare
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532154.
The Corporate was formerly known as Robinson Worldwide Trade Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 55.00 Cr and a paid-up capital of Rs 55.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Johnson Pharmacare Limited India is Ramanlal Trivedi as CFO. Manisha Maneklal, Pareshbhai Sengal, and Ramanlal Trivedi serve as directors at the Company.
- CIN/LLPIN
L51100GJ1994PLC022388
- Company No.
022388
- Stock Symbol
BSE : 532154
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Jun 1994
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Johnson Pharmacare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanlal Trivedi  | CFO | 10-May-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manisha Maneklal | Director | 14-Jun-2019 | Current |
| Pareshbhai Sengal | Director | 10-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Johnson Pharmacare.
Johnson Pharmacare Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Johnson Pharmacare?
In 2023, Johnson Pharmacare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lucent Industries LimitedActive 14 years 10 monthsManisha Maneklal and Pareshbhai Sengal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Johnson Pharmacare?
Unlock and access historical data on people associated with Johnson Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Johnson Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Johnson Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
